BF-200 ALA (Ameluz)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for BF-200 ALA (Ameluz), covering 2021-11-11 to 2026-08-21. Get the full timeline:
Most recent: Clinical Trial Results: Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp [Phase 3]